Status:
COMPLETED
Improvement Adherence to Clinical Practice Guidelines Using the Clinical Decision Support System in Patients With Hypertension and Atrial Fibrillation
Lead Sponsor:
Samara Regional Cardiology Dispensary
Collaborating Sponsors:
Medicbook LLC
Conditions:
Atrial Fibrillation
Arterial Hypertension
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The Clinical Decision Support Systems (CDSS) based on real clinical data and its own algorithms can help to make the right choice according to guidelines. The goal of the INTELLECT II study is to inve...
Detailed Description
Hypertension and atrial fibrillation are 2 important public health priorities. There is a gap between evidence-based best management and actual clinical practice. To decrease this gap, clinical practi...
Eligibility Criteria
Inclusion
- Age \> 18 years old
- Patients diagnosed with nonvalvular atrial fibrillation and hypertension and indications for therapy according to European guidelines.
Exclusion
- Inability to adhere to study procedures
- Severe heart-valve disorder
- Stroke within 14 days or severe stroke within 6 months before screening
- Active bleedings
- Thyroid dysfunction
- Pregnancy
- Secondary hypertension
Key Trial Info
Start Date :
May 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 22 2023
Estimated Enrollment :
282 Patients enrolled
Trial Details
Trial ID
NCT05367141
Start Date
May 17 2022
End Date
August 22 2023
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samara Regional Cardiology Dispansery
Samara, Russia, 443070